Calcium signaling and neurodegenerative diseases
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD) and spinocerebellar ataxias (SCAs), present an enormous medical, social, financial and scientific problem. Recent evidence indicates that neuronal calcium (Ca2+) signaling is abnormal in many of these disorders. Similar, but less severe, changes in neuronal Ca2+ signaling occur as a result of the normal aging process. The role of aberrant neuronal Ca2+ signaling in the pathogenesis of neurodegenerative disorders is discussed here. The potential utility of Ca2+ blockers for treatment of these disorders is also highlighted. It is reasoned that Ca2+ blockers will be most beneficial clinically when used in combination with other disease-specific therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Berridge, M. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80510-3 · Cited by 2,188
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097565 · Cited by 1,389
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
Arispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869 · cited 1×
“PINK1, DJ-1, LRRK2 and Parkin) (Table 1) encode proteins associated with certain aspects of mitochondrial function, which points to mitochondria as a crucial locus in PD pathogenesis [36] (Figure 2).”
BackgroundDifferent Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., & Kostka, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2617-07.2007 · Cited by 765
Volles, M. J., Lee, S.-J., Rochet, J.-C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682
Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S.-F., Hao, Y.-H., Serneels, L., De Strooper, B., Yu, G., & Bezprozvanny, I. (2006) · Cell · doi:10.1016/j.cell.2006.06.059 · Cited by 616
Self-citationKuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 587
Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization
Lin, J. W., Ju, W., Foster, K., Lee, S. H., Ahmadian, G., Wyszynski, M., Wang, Y. T., & Sheng, M. (2000) · Nature Neuroscience · doi:10.1038/81814 · Cited by 557
The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis
Van Den Bosch, L., Van Damme, P., Bogaert, E., & Robberecht, W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.002 · Cited by 491
Tang, T.-S., Tu, H., Chan, E. Y. W., Maximov, A., Wang, Z., Wellington, C. L., Hayden, M. R., & Bezprozvanny, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00366-0 · Cited by 481
Self-citationDoody, R. S., Gavrilova, S. I., Sano, M., Thomas, R. G., Aisen, P. S., Bachurin, S. O., Seely, L., & Hung, D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61074-0 · Cited by 460
Cheung, K.-H., Shineman, D., Müller, M., Cárdenas, C., Mei, L., Yang, J., Tomita, T., Iwatsubo, T., Lee, V. M.-Y., & Foskett, J. K. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.015 · Cited by 450
Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration
Kaltenbach, L. S., Romero, E., Becklin, R. R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030082 · Cited by 434
Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease
Gusella, J. F., & MacDonald, M. E. (2000) · Nature Reviews Neuroscience · doi:10.1038/35039051 · Cited by 404
Palop, J. J., Jones, B., Kekonius, L., Chin, J., Yu, G.-Q., Raber, J., Masliah, E., & Mucke, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133381100 · Cited by 402 · cited 1×
“Indeed, a tight correlation has been observed between the reduction in expression of Ca2+-binding proteins (CaBPs) in the dentate gyrus region of the hippocampus and onset of cognitive symptoms in AD [30].”
BackgroundCalpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration
Vosler, P. S., Brennan, C. S., & Chen, J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8036-x · Cited by 382
Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
Lin, X., Antalffy, B., Kang, D., Orr, H. T., & Zoghbi, H. Y. (2000) · Nature Neuroscience · doi:10.1038/72101 · Cited by 374 · cited 1×
“transgenic mouse model [79].”
Disturbed Ca2+signaling and apoptosis of medium spiny neurons in Huntington's disease
Tang, T.-S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinás, R., Kristal, B. S., Hayden, M. R., & Bezprozvanny, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409402102 · Cited by 360
Self-citationDeletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans
van de Leemput, J., Chandran, J., Knight, M. A., Holtzclaw, L. A., Scholz, S., Cookson, M. R., Houlden, H., Gwinn-Hardy, K., Fung, H.-C., Lin, X., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030108 · Cited by 343
Stutzmann, G. E., Smith, I., Caccamo, A., Oddo, S., LaFerla, F. M., & Parker, I. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0739-06.2006 · Cited by 329
Kuhn, A., Goldstein, D. R., Hodges, A., Strand, A. D., Sengstag, T., Kooperberg, C., Becanovic, K., Pouladi, M. A., Sathasivam, K., Cha, J.-H. J., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm133 · Cited by 328
Leissring, M. A., Akbari, Y., Fanger, C. M., Cahalan, M. D., Mattson, M. P., & LaFerla, F. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.4.793 · Cited by 328
Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.
Ito, E., Oka, K., Etcheberrigaray, R., Nelson, T. J., McPhie, D. L., Tofel-Grehl, B., Gibson, G. E., & Alkon, D. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.534 · Cited by 321
A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk
Dreses-Werringloer, U., Lambert, J.-C., Vingtdeux, V., Zhao, H., Vais, H., Siebert, A., Jain, A., Koppel, J., Rovelet-Lecrux, A., Hannequin, D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.048 · Cited by 318
Chan, S. L., Mayne, M., Holden, C. P., Geiger, J. D., & Mattson, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000040200 · Cited by 313
Presenilin-Mediated Modulation of Capacitative Calcium Entry
Yoo, A. S., Cheng, I., Chung, S., Grenfell, T. Z., Lee, H., Pack-Chung, E., Handler, M., Shen, J., Xia, W., Tesco, G., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00066-0 · Cited by 312
The corticostriatal pathway in Huntington's disease
CEPEDA, C., WU, N., ANDRE, V, CUMMINGS, D., & LEVINE, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.001 · Cited by 310
SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production
Green, K. N., Demuro, A., Akbari, Y., Hitt, B. D., Smith, I. F., Parker, I., & LaFerla, F. M. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200706171 · Cited by 304
Calcium homeostasis and modulation of synaptic plasticity in the aged brain
Foster, T. C. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00283.x · Cited by 302
Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial
Savani, A. A., & Login, I. S. (2007) · Neurology · doi:10.1212/01.wnl.0000259143.52138.5c · Cited by 299
Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2
Liu, J., Tang, T.-S., Tu, H., Nelson, O., Herndon, E., Huynh, D. P., Pulst, S. M., & Bezprozvanny, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0660-09.2009 · Cited by 299
Self-citationCalcium, ageing, and neuronal vulnerability in Parkinson's disease
Surmeier, D. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70246-6 · Cited by 297
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · cited 2×
“Considering the key role played by mitochondria in the pathogenesis of these disorders [88], some beneficial effects are expected in these trails.”
BackgroundInhibition of Calpain Cleavage of Huntingtin Reduces Toxicity
Gafni, J., Hermel, E., Young, J. E., Wellington, C. L., Hayden, M. R., & Ellerby, L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401267200 · Cited by 281
Stutzmann, G. E., Caccamo, A., LaFerla, F. M., & Parker, I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4386-03.2004 · Cited by 278
Mutant huntingtin and mitochondrial dysfunction
Bossy-Wetzel, E., Petrilli, A., & Knott, A. B. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.004 · Cited by 268
D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis
Sasabe, J., Chiba, T., Yamada, M., Okamoto, K., Nishimoto, I., Matsuoka, M., & Aiso, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601840 · Cited by 265
Deranged neuronal calcium signaling and Huntington disease
Bezprozvanny, I., & Hayden, M. R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.035 · Cited by 255
Self-citationUse of antihypertensives and the risk of Parkinson disease
Becker, C., Jick, S. S., & Meier, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000303818.38960.44 · Cited by 230
Familial Alzheimer disease–linked mutations specifically disrupt Ca2+ leak function of presenilin 1
Nelson, O., Tu, H., Lei, T., Bentahir, M., de Strooper, B., & Bezprozvanny, I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30447 · Cited by 226
Self-citationSanz-Blasco, S., Valero, R. A., Rodríguez-Crespo, I., Villalobos, C., & Núñez, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002718 · Cited by 219
Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3
Chen, X., Tang, T.-S., Tu, H., Nelson, O., Pook, M., Hammer, R., Nukina, N., & Bezprozvanny, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3909-08.2008 · Cited by 218
Self-citationAstrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity
Van Damme, P., Bogaert, E., Dewil, M., Hersmus, N., Kiraly, D., Scheveneels, W., Bockx, I., Braeken, D., Verpoorten, N., Verhoeven, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705046104 · Cited by 216
Nimmrich, V., Grimm, C., Draguhn, A., Barghorn, S., Lehmann, A., Schoemaker, H., Hillen, H., Gross, G., Ebert, U., & Bruehl, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4771-07.2008 · Cited by 210
Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's Disease
Tang, T.-S., Chen, X., Liu, J., & Bezprozvanny, I. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1396-07.2007 · Cited by 209
Self-citationTrinchese, F., Fa’, M., Liu, S., Zhang, H., Hidalgo, A., Schmidt, S. D., Yamaguchi, H., Yoshii, N., Mathews, P. M., Nixon, R. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34254 · Cited by 208
Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
Arispe, N., Diaz, J. C., & Simakova, O. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.014 · Cited by 193
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
Lim, D., Fedrizzi, L., Tartari, M., Zuccato, C., Cattaneo, E., Brini, M., & Carafoli, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704704200 · Cited by 193
Neuronal vulnerability in Parkinson’s disease
Hirsch, E. C., Faucheux, B., Damier, P., Mouatt-Prigent, A., & Agid, Y. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_9 · Cited by 192
Toescu, E. C., & Verkhratsky, A. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00296.x · Cited by 189
Gant, J. C., Sama, M. M., Landfield, P. W., & Thibault, O. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4171-05.2006 · Cited by 176
Riluzole in Huntington's disease: a 3‐year, randomized controlled study
Landwehrmeyer, G. B., Dubois, B., de Yébenes, J. G., Kremer, B., Gaus, W., Kraus, P. H., Przuntek, H., Dib, M., Doble, A., Fischer, W., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21181 · Cited by 176
Romero, E., Cha, G.-H., Verstreken, P., Ly, C. V., Hughes, R. E., Bellen, H. J., & Botas, J. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.025 · Cited by 170
Activated Microglia Initiate Motor Neuron Injury by a Nitric Oxide and Glutamate-Mediated Mechanism
Zhao, W., Xie, W., Le, W., Beers, D. R., He, Y., Henkel, J. S., Simpson, E. P., Yen, A. A., Xiao, Q., & Appel, S. H. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.964 · Cited by 169
Beers, D. R., Ho, B., Siklós, L., Alexianu, M. E., Mosier, D. R., Mohamed, A. H., Otsuka, Y., Kozovska, M. E., McAlhany, R. E., Smith, R. G., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00582.x · Cited by 166
Watase, K., Barrett, C. F., Miyazaki, T., Ishiguro, T., Ishikawa, K., Hu, Y., Unno, T., Sun, Y., Kasai, S., Watanabe, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804350105 · Cited by 163
Leissring, M. A., Paul, B. A., Parker, I., Cotman, C. W., & LaFerla, F. M. (1999) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1999.721061.x · Cited by 162
Zhang, H., Li, Q., Graham, R. K., Slow, E., Hayden, M. R., & Борисович, Б. И. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.010 · Cited by 144
Fan, M., Fernandes, H. B., Zhang, L. Y. J., Hayden, M. R., & Raymond, L. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4356-06.2007 · Cited by 134
Calpain Inhibition Is Sufficient to Suppress Aggregation of Polyglutamine-expanded Ataxin-3
Haacke, A., Hartl, F. U., & Breuer, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611914200 · Cited by 126
Pulst, S.-M., Santos, N., Wang, D., Yang, H., Huynh, D., Velázquez‐Pérez, L., & Figueroa, K. P. (2005) · Brain · doi:10.1093/brain/awh586 · Cited by 124
Multiple pathways contribute to the pathogenesis of Huntington disease.
Li, S., & Li, X. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-19 · Cited by 122
Shehadeh, J., Fernandes, H. B., Zeron Mullins, M. M., Graham, R. K., Leavitt, B. R., Hayden, M. R., & Raymond, L. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.001 · Cited by 122
Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease
Wang, X., Zhu, S., Pei, Z., Drozda, M., Stavrovskaya, I. G., Del Signore, S. J., Cormier, K., Shimony, E. M., Wang, H., Ferrante, R. J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1867-08.2008 · Cited by 120
Evaluation of Dimebon in cellular model of Huntington's disease
Wu, J., Li, Q., & Bezprozvanny, I. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-15 · Cited by 117
Self-citationFurukawa, K., Matsuzaki‐Kobayashi, M., Hasegawa, T., Kikuchi, A., Sugeno, N., Itoyama, Y., Wang, Y., Yao, P. J., Bushlin, I., & Takeda, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03803.x · Cited by 113
Rybalchenko, V., Hwang, S., Rybalchenko, N., & Koulen, P. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.023 · Cited by 106
Simakova, O., & Arispe, N. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3006-07.2007 · Cited by 105
Lee, G., Pollard, H. B., & Arispe, N. J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00060-8 · Cited by 104
A pilot study of the clinical efficacy and safety of memantine for Huntington's disease
Ondo, W. G., Mejia, N. I., & Hunter, C. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.08.005 · Cited by 98
Calcium: the Darth Vader of ALS
Appel, S. H., Beers, D. R., Siklós, L., Engelhardt, J., & Mosier, D. R. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201300079418 · Cited by 98
Tang, T.-S., Guo, C., Wang, H., Chen, X., & Борисович, Б. И. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4411-08.2009 · Cited by 98
Piedras-Renterı́a, E. S., Watase, K., Harata, N., Zhuchenko, O., Zoghbi, H. Y., Lee, C. C., & Tsien, R. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09185.2001 · Cited by 86
Cowan, C. M., Fan, M., Fan, J., Shehadeh, J., Zhang, L. Y. J., Graham, R. K., Hayden, M. R., & Raymond, L. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4619-08.2008 · Cited by 72
Wu, J., Tang, T.-S., & Борисович, Б. И. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.036 · Cited by 56
Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels
Swayne, L. A., Chen, L., Hameed, S., Barr, W., Charlesworth, E., Colicos, M. A., Zamponi, G. W., & Braun, J. E. A. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.07.016 · Cited by 52
No Association between CALHM1 and Alzheimer's Disease Risk
Bertram, L., Schjeide, B. M., Hooli, B. V., Mullin, K., Hiltunen, M. O., Soininen, H. S., Ingelsson, M., Lannfelt, L., Blacker, D., & Tanzi, R. E. (2008) · Cell · doi:10.1016/j.cell.2008.11.030 · Cited by 51
BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
Seabrook, G. R., Ray, W. J., Shearman, M., & Hutton, M. (2007) · Molecular Interventions · doi:10.1124/mi.7.5.8 · Cited by 48
The Presenilin-2 Loop Peptide Perturbs Intracellular Ca2+ Homeostasis and Accelerates Apoptosis
Cai, C., Lin, P., Cheung, K., Li, N., Levchook, C., Pan, Z., Ferrante, C., Boulianne, G. L., Foskett, J. K., Danielpour, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512026200 · Cited by 46
ALS: life and death in a bad neighborhood
Monk, P. N., & Shaw, P. J. (2006) · Nature Medicine · doi:10.1038/nm0806-885 · Cited by 45
Calcium homeostasis and spinocerebellar ataxia-1 (SCA-1).
Vig, P. J., Subramony, S., & McDaniel, D. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00595-0 · Cited by 30
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“312 – 315 Maintaining this calcium homeostasis is fundamental to calcium signaling, and disruption in cytosolic calcium concentration gradients, as well as abnormalities in calcium signaling pathways, may lead to neurodegenerative diseases such as AD and Parkinson ’ s disease (PD), cardiovascular…”
BackgroundThe Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 753
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Sanchez, P. E., Zhu, L., Verret, L., Vossel, K. A., Orr, A. G., Cirrito, J. R., Devidze, N., Ho, K., Yu, G.-Q., Palop, J. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121081109 · Cited by 638
A Molecular Web: Endoplasmic Reticulum Stress, Inflammation, and Oxidative Stress
Chaudhari, N., Talwar, P., Parimisetty, A., Lefebvre d’Hellencourt, C., & Ravanan, P. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00213 · Cited by 600
“…radical production (Gandhi and Abramov, 2012), excitotoxicity (Dong et al., 2009), neuroinflammation (Glass et al., 2010), disruption of calcium-regulating systems (Bezprozvanny, 2009), mitochondrial dysfunction (Lezi and Swerdlow, 2012), and misfolded protein accumulation (Matus et al., 2011).”
Background
Metadata
- Authors
- Bezprozvanny, I.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 15
- Issue
- 3
- Pages
- 89-100
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1974888639
- Cited by
- 469
- References
- 92
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.